Published in J Clin Invest on August 01, 1986
Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci U S A (2006) 3.73
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells. Br J Cancer (2008) 1.24
Cloning of the novel human myeloid-cell-specific C/EBP-epsilon transcription factor. Mol Cell Biol (1997) 1.22
Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. J Clin Invest (2002) 1.12
Granulocyte-macrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes. J Clin Invest (1987) 1.07
1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice. Proc Natl Acad Sci U S A (1990) 1.07
Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma. Br J Cancer (2010) 1.07
Vitamin D and differentiation in cancer. Crit Rev Clin Lab Sci (2009) 1.05
A differential screen for ligand-regulated genes: identification of HoxA10 as a target of vitamin D3 induction in myeloid leukemic cells. Mol Cell Biol (1998) 0.95
Impact of vitamin D metabolism on clinical epigenetics. Clin Epigenetics (2011) 0.90
Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid. J Clin Invest (1997) 0.87
The sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites. J Steroid Biochem Mol Biol (2013) 0.84
Synergistic inhibition of prostate cancer cell lines by a 19-nor hexafluoride vitamin D3 analogue and anti-activator protein 1 retinoid. Br J Cancer (1999) 0.81
Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogs. Front Oncol (2014) 0.81
1,25-Dihydroxyvitamin D3-mediated inhibition of human B cell differentiation. Clin Exp Immunol (1987) 0.81
Selective expression of a normal action of the 1,25-dihydroxyvitamin D3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor. J Clin Invest (1989) 0.81
Novel therapeutic approach: organic arsenical melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo. Br J Cancer (2000) 0.80
EphB6 overexpression and Apc mutation together promote colorectal cancer. Oncotarget (2016) 0.79
Oncoprotein Cot1 represses kinase suppressors of Ras1/2 and 1,25-dihydroxyvitamin D3-induced differentiation of human acute myeloid leukemia cells. J Cell Physiol (2011) 0.78
NADPH-cytochrome P450 reductase is regulated by all-trans retinoic acid and by 1,25-dihydroxyvitamin D3 in human acute myeloid leukemia cells. PLoS One (2014) 0.78
Restored expression of vitamin D receptor and sensitivity to 1,25-dihydroxyvitamin D3 in response to disrupted fusion FOP2-FGFR1 gene in acute myeloid leukemia cells. Cell Biosci (2016) 0.75
Induced myelomonocytic differentiation in leukemia cells is accompanied by noncanonical transcription factor expression. FEBS Open Bio (2015) 0.75
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood (1975) 15.95
Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer (1976) 14.08
Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature (1977) 12.57
Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer (1980) 10.11
1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science (1983) 4.34
Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A (1981) 4.12
HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science (1982) 4.07
Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science (1978) 3.91
Differentiation of a cell line of myeloid leukemia. J Cell Physiol (1969) 3.73
Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature (1984) 3.06
1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol (1984) 2.01
gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem Biophys Res Commun (1985) 1.97
The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr Rev (1982) 1.92
An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood (1980) 1.86
1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem J (1982) 1.63
1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci U S A (1983) 1.60
Human T lymphocyte cell line producing colony-stimulating activity. Blood (1978) 1.40
Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res (1984) 1.37
Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol. Cancer Res (1983) 1.37
Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells. J Clin Invest (1982) 1.33
Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation. Cancer Res (1981) 1.33
1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat Rep (1985) 1.20
Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): a morphologic, phenotypic, and functional analysis. Blood (1984) 1.01
A blast subclone of the HL-60 human promyelocytic cell line. Leuk Res (1981) 0.96
Retinoic acid enhances colony-stimulating factor-induced clonal growth of normal human myeloid progenitor cells in vitro. Exp Cell Res (1982) 0.91
Functional defect of variant clones of a human myeloid leukemia cell line (HL-60) resistant to 1 alpha,25-dihydroxyvitamin D3. Endocrinology (1983) 0.87
Phenotypic differentiation-linked growth inhibition in human leukemia cells by active vitamin D3 analogues. Int J Cancer (1984) 0.84
A fluorinated vitamin D3 analog with biopotency greater than 1 alpha, 25-dihydroxy vitamin D3. Biochem Biophys Res Commun (1980) 0.82
Specific uptake of 1,25-dihydroxycholecalciferol by human chronic myeloid leukemia cells. Cancer Res (1984) 0.78
The effect of vitamin D3 metabolites on normal and leukemic bone marrow cells in vitro. Int J Cell Cloning (1984) 0.78
Myeloid leukemic cell differentiation induced by human postendotoxin serum and vitamin analogues. Haematol Blood Transfus (1983) 0.78
On the Interpretation of Multi-Hit Survival Curves. Proc Natl Acad Sci U S A (1949) 5.96
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol (1997) 5.89
Human p53 gene localized to short arm of chromosome 17. Nature (1986) 4.67
Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A (1987) 4.21
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol (2002) 3.98
Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science (1978) 3.91
Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci U S A (1998) 3.46
The role of the vitamin D endocrine system in health and disease. N Engl J Med (1989) 3.37
Effect of reactive pharmacy intervention on quality of hospital prescribing. BMJ (1990) 3.25
Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol (2003) 3.10
Amygdalin (Laetrile): effect on clonogenic cells from human myeloid leukemia cell lines and normal human marrow. Cancer Treat Rep (1980) 2.86
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer. Ann Oncol (1997) 2.71
Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res (1998) 2.67
Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Nature (1986) 2.56
Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res (2001) 2.53
Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem (1999) 2.47
Bile acid transformations by microbial strains belonging to genera found in intestinal contents. Acta Pathol Microbiol Scand (1967) 2.33
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest (1993) 2.25
Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer. J Clin Oncol (1995) 2.08
A potential transcriptional activation element in the p53 protein. Oncogene (1990) 2.07
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol (1994) 2.02
1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol (1984) 2.01
Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood (1983) 2.01
Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene (2008) 1.97
gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem Biophys Res Commun (1985) 1.97
Human myeloid leukemia cell lines: a review. Blood (1980) 1.96
Absence of WAF1 mutations in a variety of human malignancies. Blood (1994) 1.95
p27/Kip1 mutation found in breast cancer. Cancer Res (1996) 1.94
1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1987) 1.89
Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells. Blood (1996) 1.89
Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis. Medicine (Baltimore) (1991) 1.89
Myeloid transcription factor C/EBPepsilon is involved in the positive regulation of lactoferrin gene expression in neutrophils. Blood (1999) 1.88
An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood (1980) 1.86
Update on desmoid tumors. Ann Oncol (2011) 1.82
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer (1999) 1.80
Kaposi's sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV8)-associated lymphoma of the bowel. Report of two cases in HIV-positive men with secondary effusion lymphomas. Am J Surg Pathol (1997) 1.79
Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood (1995) 1.76
Proliferation of human lymphocytes in culture. Nature (1966) 1.76
A comparison of treatment planning techniques used in two randomised UK external beam radiotherapy trials for localised prostate cancer. Clin Oncol (R Coll Radiol) (2007) 1.75
A test for the practical evaluation of male fertility by acridine orange (AO) fluorescence. Fertil Steril (1984) 1.68
FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study. Br J Cancer (2000) 1.68
Characterization of cDNA clones for human myeloperoxidase: predicted amino acid sequence and evidence for multiple mRNA species. Nucleic Acids Res (1987) 1.67
Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphoma. Leukemia (2006) 1.67
Weight history, glucose intolerance, and insulin levels in middle-aged Swedish men. Am J Epidemiol (1998) 1.66
A genetic register for von Hippel-Lindau disease. J Med Genet (1996) 1.61
Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol (1999) 1.59
Rapid destructive osteoarthritis: clinical, radiographic, and pathologic features. Radiology (1992) 1.56
The mutational spectrum in Waardenburg syndrome. Hum Mol Genet (1995) 1.55
25-Hydroxyvitamin D3 metabolism by lipopolysaccharide-stimulated normal human macrophages. J Clin Endocrinol Metab (1987) 1.54
Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood (1997) 1.54
Molecular genetic advances in chronic myelogenous leukemia. Ann Intern Med (1990) 1.54
Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J Biol Chem (2001) 1.52
Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood (2001) 1.50
Parameters in 7-alpha-dehydroxylation of bile acids by anaerobic lactobacilli. Acta Pathol Microbiol Scand (1968) 1.50
A randomized study of the use of a customized immobilization system in the treatment of prostate cancer with conformal radiotherapy. Radiother Oncol (2000) 1.49
DNA aneuploidy in morphologically normal colons from patients with colon cancer. Mod Pathol (1995) 1.48
BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1). Oncogene (2006) 1.48
CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. J Clin Invest (1999) 1.45
Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer (2002) 1.45
Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines. Cancer Res (1997) 1.44
Predicting normal tissue injury in radiation therapy. Int J Radiat Oncol Biol Phys (1991) 1.43
Endoscopic evaluation of the gastro-duodenal tolerance of short-term analgesic treatment with 25 mg diclofenac-K liquid capsules. Aliment Pharmacol Ther (2012) 1.43
Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins. Mol Cell Biol (1999) 1.43
Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood (1995) 1.42
Using intact nerve to bridge peripheral nerve defects: an alternative to the use of nerve grafts. J Hand Surg Am (2001) 1.42
Myeloperoxidase: its structure and expression during myeloid differentiation. Blood (1985) 1.41
Characterization of a novel HTLV-infected cell line. Blood (1984) 1.40
Is supplementation with elemental diet feasible in patients undergoing pelvic radiotherapy? Clin Nutr (2005) 1.39
Exonic STK11 deletions are not a rare cause of Peutz-Jeghers syndrome. J Med Genet (2006) 1.39
Microwave life-detection systems for searching human subjects under earthquake rubble or behind barrier. IEEE Trans Biomed Eng (2000) 1.39
Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. Blood (2000) 1.38
Inhibition of norfloxacin absorption by antacids. Antimicrob Agents Chemother (1990) 1.38
Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res (1984) 1.37
p53 in hematologic malignancies. Blood (1994) 1.37
Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. J Biol Chem (2000) 1.37
Isolated fecal microorganisms capable of 7-alpha-dehydroxylating bile acids. J Exp Med (1966) 1.36
The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes. Eur J Immunol (1994) 1.36
Regulation of expression of murine transferrin receptor 2. Blood (2001) 1.35
Myositis ossificans with atypical clinical, radiographic, or pathologic findings: a review of 23 cases. Skeletal Radiol (1992) 1.34
p53 mutations in human lung tumors. Cancer Res (1992) 1.33
Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res (1990) 1.33
Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation. Cancer Res (1981) 1.33
Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells. J Clin Invest (1982) 1.33
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood (1996) 1.33
The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene (2007) 1.32
Determination of bile acid conversion potencies of intestinal bacteria by screening in vitro and subsequent establishment in germfree rats. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 1.32
N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome. Blood (1993) 1.32
Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours. Eur J Cancer (1995) 1.31
Oral hydralazine therapy for chronic refractory heart failure. Circulation (1976) 1.30
Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood (1998) 1.30
Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer. Cancer Res (2000) 1.30
Gamma-interferon induces expression of the HLA-D antigens on normal and leukemic human myeloid cells. Proc Natl Acad Sci U S A (1984) 1.29
Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification. Cancer Res (1993) 1.29
A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation. Blood (1997) 1.29
Distended left renal vein: CT/sonographic normal variant. AJR Am J Roentgenol (1980) 1.28
Dlk1 in normal and abnormal hematopoiesis. Leukemia (2005) 1.28